Please provide your email address to receive an email when new articles are posted on . The collaboration aims to improve the recovery and assessment of livers for transplantation. Increasing the ...
OXFORD, United Kingdom and CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- OrganOx Ltd., a medical technology company developing innovative solutions for organ preservation, and eGenesis, Inc., a ...
British Growth Fund (BGF), a UK- and Ireland-based growth capital investor, has successfully exited Oxford University spinout OrganOx, a medtech company that develops a liver preservation device, in a ...
The FDA has cleared the first clinical trial to test genetically engineered pig livers in patients who have acute-on-chronic liver failure. The trial will evaluate the use of a Egenesis porcine liver ...
Organox Ltd.’s normothermic machine perfusion device, Metra, has been cleared by the U.S. FDA for use during air transport. The greenlight from the regulatory body paves the way for the broader use of ...
BGF first invested in OrganOx in 2019 The deal has driven a 10x money multiple exit on BGF’s initial investment OrganOx was founded out of the University of Oxford BGF has exited its investment in ...
Organox Ltd. raised $142 million in financing to accelerate the growth of its Metra platform that preserves and transport livers for transplantation. The funds will allow the company to strengthen its ...
Add Yahoo as a preferred source to see more of our stories on Google. This photo provided by eGenesis on Jan. 18, 2024 shows a genetically modified pig liver in Massachusetts before transportation to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results